Luca Palombi: Venolymphatic Plexus Incompetence in Recurrent Varicose Veins
Luca Palombi, Vascular Surgeon and Co-Founder at Cura Vene Roma, shared a post on LinkedIn:
“Recurrent varicose veins are often attributed to neovascularization.
But is this always the correct explanation?
In my clinical experience, a subset of recurrences appears to originate from a different anatomical substrate: an incompetent venolymphatic plexus associated with an inguinal lymph node.
Rather than representing ‘new vessels’ alone, these cases seem to involve a pre-existing intranodal microvascular network that, following surgery or endovenous ablation, undergoes remodeling and progressively becomes hemodynamically significant.
The proposed mechanism is straightforward:
- Elevated pressure from the common femoral vein is transmitted into an incompetent intranodal venolymphatic plexus.
- The plexus then acts as an intermediary reflux reservoir, directing blood centrifugally into superficial tributaries.
- The result is recurrent varicose veins despite durable occlusion of the treated saphenous trunk.
On duplex ultrasound, this pattern may appear as a cluster of tortuous vessels converging within or immediately adjacent to an inguinal lymph node, demonstrating reflux during dynamic maneuvers.
Recognizing this anatomical configuration is important because treatment should focus on the refluxing venolymphatic plexus, rather than simply removing or ablating the recurrent superficial varicosities.
From a therapeutic perspective, I believe ultrasound-guided foam sclerotherapy (UGFS) represents the treatment of choice in these cases. Beyond its effectiveness in obliterating the incompetent venolymphatic network, UGFS avoids the delivery of thermal energy in close proximity to the lymph node, thereby minimizing the potential risk of thermal injury to nodal structures and the surrounding lymphatic pathways.
I would be very interested to hear your experience and discuss whether this entity should be differentiated from classical neovascularization.”

Stay updates with Hemostasis Today.
-
Sep 11, 2026, 13:35How Non-Factor Therapies Are Changing Hemophilia Care – Seminars in Thrombosis and Hemostasis
-
Sep 11, 2026, 13:21Emmanuel J Favaloro: Rethinking Quality Control in VWD Testing
-
Sep 11, 2026, 13:10Tessa Youngner: New Free E-Course Introduces Comprehensive SCD Care
-
Sep 11, 2026, 12:55Identifying Key Research Priorities for VTE and Stroke – International Journal of Stroke
-
Sep 11, 2026, 12:43Helping Hematology Employers Reach Qualified Job Seekers – ASH
-
Sep 11, 2026, 12:22The First New Treatment for Essential Thrombocythemia in Nearly 30 Years
-
Sep 11, 2026, 12:20When Thrombosis Affects the Kidneys – World Thrombosis Day
-
Sep 11, 2026, 11:24Haroun Gajraj: Polidocanol or STS – Choosing the Right Sclerosant
-
Sep 11, 2026, 10:53A Patient-Centred Approach to Haemophilia B Care – EAHAD